HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L C Johnston Selected Research

Serotonin 5-HT1 Receptor Agonists

8/2010An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L C Johnston Research Topics

Disease

1Parkinsonian Disorders (Parkinsonism)
08/2010
1Dyskinesias (Dyskinesia)
08/2010
1Parkinson Disease (Parkinson's Disease)
08/2010
1Psychotic Disorders (Schizoaffective Disorder)
08/2010
1Aneurysm (Aneurysms)
02/2001
1Fistula
02/2001

Drug/Important Bio-Agent (IBA)

1Serotonin 5-HT1 Receptor AgonistsIBA
08/2010
15-HT1A Serotonin ReceptorIBA
08/2010
1pardoprunoxIBA
08/2010
1Dopamine (Intropin)FDA LinkGeneric
08/2010

Therapy/Procedure

1Endovascular Aneurysm Repair
02/2001
1Stents
02/2001